Tevogen Bio Holdings Healthcare Acquisition | M&A Deal

Tevogen Bio Holdings has announced a platform acquisition strategy for healthcare services other opportunities in New Jersey, with potential to support approximately $100 million in combined annual revenue. The company is evaluating acquisitions that could expand its healthcare services arm, potentially including management services and contract research operations, alongside its Tevogen Bio biotechnology and Tevogen.AI technology businesses. Tevogen Bio Holdings acquisitions are intended to build a revenue-generating healthcare enterprise through healthcare M&A and public company acquisition initiatives based in NJ. The healthcare deals NJ plan remains subject to approvals and customary conditions, and Tevogen expects capital discipline and strategic fit to guide any healthcare services other acquisition decisions.